NCT04720183View on ClinicalTrials.gov

Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 11, 2021

Primary Completion Date

April 21, 2021

Study Completion Date

April 23, 2021

Conditions
Healthy
Interventions
DRUG

Sulfasalazine

On Day 1, Day 5 and Day 9, a single oral dose of sulfasalazine tablets in fasted state.

DRUG

GLPG3970

On Day 5 and Day 9, a single dose of GLPG3970 oral solution in fasted state.

Trial Locations (1)

07103

Biotral Inc, Newark

Sponsors

Lead Sponsor

Galapagos NV
All Listed Sponsors
lead

Galapagos NV

INDUSTRY